Heather Preston is Managing Director at TPG Biotech. Prior to joining TPG Biotech in 2005, Dr. Preston worked in investment banking at JP Morgan Partners, served as an Entrepreneur-in-Residence with New Enterprise Associates, and was a leader of the pharmaceutical and medical products consulting practice at McKinsey & Co. She has an undergraduate degree in biochemistry from the University of London, a medical degree from the University of Oxford, and a post-doctoral fellowship in molecular biology at the Dana Farber Cancer Institute, Harvard University.
She completed her training in Internal Medicine at the Massachusetts General Hospital and then sub-specialized in Gastroenterology and Hepatology at University of California, San Francisco. During her academic career, Dr. Preston was the recipient of a Fulbright Scholarship, a Fulbright Cancer Research Scholarship, a Harlech Scholarship and a Science and Engineering Research Council Post-Doctoral Fellowship Award. In addition to Albireo, Dr. Preston serves on the Board of Directors of Alder Biotherapeutics (NASDAQ: ALDR) and numerous private companies.